Search results
... Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory...
Morningstar· 4 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell ...
Atezolizumab Consolidation Impresses in High-Risk DLBCL
MedPage Today· 5 days agoPostchemotherapy consolidation with atezolizumab (Tecentriq) led to a surprisingly high 2-year...
EHA 2024: Roche’s Columvi competes in BiTE battle with positive results in DLBCL
Pharmaceutical Technology via Yahoo Finance· 2 days agoBased on the latest STARGLO trial results, there is potential to extend Columvi into earlier lines...
Campaign fuels efforts to find better treatments for blood cancers in children
NBC Dallas Fort Worth· 11 hours agoLeukemia and Lymphoma Society's (LLS) Dare to Dream project hopes to raise money for research of...
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
Zacks via Yahoo Finance· 2 days agoRoche's (RHHBY) Columvi significantly extends survival in patients with relapsed or refractory...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo Finance· 13 hours agoThe BLA is seeking the approval of the candidate in R/R follicular lymphoma (FL) and R/R diffuse ...
Three-Drug Regimen Shows OS Benefit in Third-Line DLBCL
MedPage Today· 2 days agoLoretta Nastoupil, MD, leads a discussion on the ECHELON-3 trial results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 7 days agoIn one study, Pfizer's Seagen-acquired drug, Adcetris, reduced the risk of death by 37% for patients...
Roche’s Columvi offers extended survival in Phase III DLBCL trial
Clinical Trials Arena via Yahoo Finance· 2 days agoRoche has reported findings from the Phase III STARGLO clinical trial where Columvi, in combination...
Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with...
Benzinga· 3 days agoDr. Kim Linton, M.B.Ch.B, MRCP, Ph.D., FRCP, senior lecturer at the University of Manchester, a consultant at...